Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations

Bacillus Calmette-Guérin (BCG) plays a cornerstone role in the management of nonmuscle invasive urothelial carcinoma of the bladder. However, there has been a worldwide intermittent BCG shortage in recent years that may affect the care of patients with bladder cancer and pose difficult clinical deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Wroclawski, Marcelo Langer, Schutz, Fabio A., Cha, Jonathan Doyun, Soares, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776038/
https://www.ncbi.nlm.nih.gov/pubmed/31454284
http://dx.doi.org/10.1200/JGO.19.00112
_version_ 1783456353462779904
author Wroclawski, Marcelo Langer
Schutz, Fabio A.
Cha, Jonathan Doyun
Soares, Andrey
author_facet Wroclawski, Marcelo Langer
Schutz, Fabio A.
Cha, Jonathan Doyun
Soares, Andrey
author_sort Wroclawski, Marcelo Langer
collection PubMed
description Bacillus Calmette-Guérin (BCG) plays a cornerstone role in the management of nonmuscle invasive urothelial carcinoma of the bladder. However, there has been a worldwide intermittent BCG shortage in recent years that may affect the care of patients with bladder cancer and pose difficult clinical decisions to urologists and clinical oncologists. This literature review aims to clarify alternatives to BCG during a shortage and propose measures to replace BCG, mainly in Brazil and probably in other low- and middle-income countries, where not all studied and commonly suggested treatments are available.
format Online
Article
Text
id pubmed-6776038
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-67760382019-10-04 Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations Wroclawski, Marcelo Langer Schutz, Fabio A. Cha, Jonathan Doyun Soares, Andrey J Glob Oncol Special Article Bacillus Calmette-Guérin (BCG) plays a cornerstone role in the management of nonmuscle invasive urothelial carcinoma of the bladder. However, there has been a worldwide intermittent BCG shortage in recent years that may affect the care of patients with bladder cancer and pose difficult clinical decisions to urologists and clinical oncologists. This literature review aims to clarify alternatives to BCG during a shortage and propose measures to replace BCG, mainly in Brazil and probably in other low- and middle-income countries, where not all studied and commonly suggested treatments are available. American Society of Clinical Oncology 2019-08-27 /pmc/articles/PMC6776038/ /pubmed/31454284 http://dx.doi.org/10.1200/JGO.19.00112 Text en © 2019 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Special Article
Wroclawski, Marcelo Langer
Schutz, Fabio A.
Cha, Jonathan Doyun
Soares, Andrey
Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
title Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
title_full Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
title_fullStr Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
title_full_unstemmed Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
title_short Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
title_sort alternative therapies to bacillus calmette-guérin shortage for nonmuscle invasive bladder cancer in brazil and other underdeveloped countries: management considerations
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776038/
https://www.ncbi.nlm.nih.gov/pubmed/31454284
http://dx.doi.org/10.1200/JGO.19.00112
work_keys_str_mv AT wroclawskimarcelolanger alternativetherapiestobacilluscalmetteguerinshortagefornonmuscleinvasivebladdercancerinbrazilandotherunderdevelopedcountriesmanagementconsiderations
AT schutzfabioa alternativetherapiestobacilluscalmetteguerinshortagefornonmuscleinvasivebladdercancerinbrazilandotherunderdevelopedcountriesmanagementconsiderations
AT chajonathandoyun alternativetherapiestobacilluscalmetteguerinshortagefornonmuscleinvasivebladdercancerinbrazilandotherunderdevelopedcountriesmanagementconsiderations
AT soaresandrey alternativetherapiestobacilluscalmetteguerinshortagefornonmuscleinvasivebladdercancerinbrazilandotherunderdevelopedcountriesmanagementconsiderations

Ejemplares similares